Clinical research in breast cancer remains as active as ever, with newer interventions being tested in ever larger and/or more complex trial designs.
Most groups operated on the basis of financial reimbursement per enrolled patient, and the UK model subsequently evolved to a hybrid system for more complex trials.
Mr DiMasi says the increase has been caused by larger and more complex trials, a greater focus on chronic and degenerative diseases, and higher failure rates.However, the life-saving cancer drugs that feature in many of the most emotional disputes over pricing are far from typical.
Capital cases involve more complex trials and multiple appeals over the average 15 years that a convict spends on death row, where the costs of solitary confinement and security are astronomical compared with the general prison population.
A guilty verdict would not of itself prove Mr Skilling's guilt, but if prosecutors are unable to win a conviction in this relatively simple case, that might not bode well for the more complex trials of the bigger fish to come.
Results indicate that accuracy profiles are similar in the two conditions; however, the patterns of data measuring inhibitory control, i.e., percentage of intrusion errors, are opposite in the case of verbal (intrusions decreased in more complex trials) and visuo-spatial (intrusions increased in more complex trials) material.
The typical 4-antennas/reader combination has been used, in order to simplify the field trial; however, a more complex antennas multiplexing should be used in an hypothetical wider deployment (at least 32 antennas/reader).
Yet as the trial has unfolded, a more complex picture has emerged.
In practice several other methods are available for debriding wounds, and thus when making choices about type of debridement treatment decision makers are faced with a more complex decision than that represented by this trial.
While simple qualitative techniques are sufficient for many routine clinical examinations, an increase in the use of PET with FDG, and also novel tracers reflecting different pharmacodynamic end points in clinical trials, often necessitates a more complex and quantitative approach.
